GeneDx Holdings Corp. — Director's Dealing 2021

Oct 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sema4 Holdings Corp. (SMFR)
CIK: 0001818331
Period of Report: 2021-10-01

Reporting Person: Saad Kareem (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-01	Employee Stock Option (Right to Buy)	$7.62	A	192152	Acquired	2031-09-30	Class A Common Stock (192152)	Direct
2021-10-01	Restricted Stock Unit	$	A	288228	Acquired		Class A Common Stock (288228)	Direct

Footnotes

F1: 3/16th of the total shares vest on October 25, 2021, 1/16th of the total shares vest on January 19, 2022, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on January 19, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.

F2: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.